UnknownNot Applicable

Psychosocial Factors a Prognostic Study of Pain in Patients With CMC Osteoarthritis

United States50 participantsStarted 2019-04-01

Plain-language summary

In this clinical trial, females with a diagnosis of thumb CMC OA, will be recruited. The primary outcome of potential risk factors of osteoarthritis, pain and function will be measured using the demographic data, visual analog scale (VAS) and Disabilities of the Arm, Shoulder and Hand (QuickDASH). Secondary out-comes will include the Pain Self-Efficacy Questionnaire (PSEQ), Tampa Scale of Kinesiophobia (TSK), Fear Avoidance Beliefs Questionnaire (FABQ), Hospital Anxiety and Depression Scale (HADS) and Impairment and Functioning Inventory (IFI). Measurements will be taken at the baseline, three, six and 12 months follow up.

Who can participate

Age range18 Years – 90 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * women older than 18 years * diagnosed with bilateral thumb CMC OA * a reported pain intensity during activities of daily living (ADLs) of up to 4 of 10 on the visual analog scale (VAS) * The referring hand surgeon will made the diagnosis of CMC OA based on radiographs and clinical exploration. Exclusion Criteria: * neurologic disorder affecting the upper limb * had received previous treatment for their hand problem in the last 6 months including an intra-articular joint injection to wrist, fingers, or thumb * had fractures or a significant hand injury or previous surgery to the wrist or hand * had hand or finger tenosynovitis and/or Dupuytren disease * patients who did not complete any questionnaire or if they did not sign the informed consent.

What they're measuring

Change from baseline to 12 months Visual Analog Scale (VAS)

Timeframe: baseline, three, six and 12 months follow up

Change from baseline to 12 months Quick Disabilities of the Arm, Shoulder and Hand

Timeframe: baseline, three, six and 12 months follow up

Trial details

NCT IDNCT03821298

SponsorGannon University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-04-01

Contact for this trial

Kristin Valdes, OTD, OT, CHT

813 6584901 valdes001@gannon.edu